IRVINE, Calif., Feb. 12, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) announced today that it will release its fourth quarter 2013 financial results on Wednesday, February 19, 2014. Results will be released prior to trading on that day.
A conference call has also been scheduled regarding CombiMatrix Corporation's fourth quarter 2013 financial results. The presentation and Q&A session will start at 8:00 a.m. Pacific Time (11:00 a.m. Eastern) on February 19, 2014.
To attend the presentation by phone, dial 1-888-287-5563 for domestic callers and 1-719-457-2661 for direct-dial or international callers. To listen to the call via CombiMatrix's website, go to www.combimatrix.com in the Investor/Events section (http://investor.combimatrix.com/events.cfm).
A replay of the presentation will be available following the presentation, either via the CombiMatrix website Investor/Events section (http://investor.combimatrix.com/events.cfm) or by dialing 1-877-870-5176 for domestic callers or 1-858-384-5517 for direct-dial international callers. When prompted, enter playback pin number 8996370.
About CombiMatrix Corporation
CombiMatrix Corporation provides valuable molecular diagnostic solutions and comprehensive clinical support for the highest quality of care -- specializing in miscarriage analysis, prenatal and pediatric healthcare. CombiMatrix offers comprehensive testing services for the detection of abnormalities of genes at the DNA level beyond what can be identified through traditional technologies. The Company performs genetic testing utilizing microarray, FISH, PCR and G-Band chromosome analyses. Additional information about CombiMatrix is available at www.combimatrix.com or by calling 1-800-710-0624.
CONTACT: Company Contact: Mark McDonough President & CEO, CombiMatrix Corporation Tel (949) 753-0624 Investor Relations / Media Contact: Matt Clawson Partner Allen & Caron, Inc. Tel (949) 474-4300 firstname.lastname@example.org